Maze Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TRV GP IV, LLC | 11/13/2025 | 6.07 M | $157.50 M | 0.00% | 13.85% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 4.57 M | $118.43 M | 0.00% | 10.42% |
| ARCH VENTURE MANAGEMENT, LLC | 11/14/2025 | 4.12 M | $106.83 M | 0.00% | 9.40% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 3.95 M | $102.40 M | 0.00% | 9.01% |
| ALPHABET INC. | 11/07/2025 | 2.41 M | $62.56 M | 0.00% | 5.50% |
| AH CAPITAL MANAGEMENT, L.L.C. | 11/14/2025 | 1.70 M | $44.14 M | 0.00% | 3.88% |
| MATRIX CAPITAL MANAGEMENT COMPANY, LP | 11/13/2025 | 1.65 M | $42.88 M | -33.49% | 3.77% |
| VANGUARD GROUP INC | 11/07/2025 | 1.33 M | $34.62 M | 218.14% | 3.04% |
| BLACKROCK, INC. | 11/12/2025 | 1.32 M | $34.12 M | 114.09% | 3.00% |
| VR ADVISER, LLC | 11/14/2025 | 1.23 M | $31.91 M | 100.00% | 2.81% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 1.23 M | $31.82 M | 100.57% | 2.80% |
| GENERAL CATALYST GROUP MANAGEMENT, LLC | 11/14/2025 | 1.04 M | $26.86 M | 0.00% | 2.36% |
| WOODLINE PARTNERS LP | 11/14/2025 | 1.04 M | $26.84 M | 10.05% | 2.36% |
| TRV GP V, LLC | 11/13/2025 | 950.80 K | $24.65 M | 0.00% | 2.17% |
| MARSHALL WACE, LLP | 11/13/2025 | 777.70 K | $20.17 M | 3,868.47% | 1.77% |
| CASDIN CAPITAL, LLC | 11/14/2025 | 758.86 K | $19.68 M | 0.00% | 1.73% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 751.87 K | $19.49 M | -46.34% | 1.71% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 740.83 K | $19.21 M | 181.96% | 1.69% |
| FMR LLC | 11/13/2025 | 655.61 K | $17.00 M | 18.23% | 1.50% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2025 | 545.13 K | $14.14 M | 100.00% | 1.24% |
| FORESITE CAPITAL MANAGEMENT IV, LLC | 11/14/2025 | 522.66 K | $13.55 M | -75.25% | 1.19% |
| BESSEMER GROUP INC | 11/05/2025 | 481.79 K | $12.49 M | 0.00% | 1.10% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 473.55 K | $12.28 M | 104.79% | 1.08% |
| HHLR ADVISORS, LTD. | 11/14/2025 | 457.54 K | $11.86 M | 0.00% | 1.04% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 433.73 K | $11.25 M | 100.00% | 0.99% |
| STATE STREET CORP | 11/14/2025 | 384.70 K | $9.98 M | 165.89% | 0.88% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 378.02 K | $9.80 M | 95.46% | 0.86% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 351.88 K | $9.12 M | 365.87% | 0.80% |
| MORGAN STANLEY | 11/14/2025 | 212.76 K | $5.52 M | 569.46% | 0.49% |
| WASHINGTON UNIVERSITY | 11/03/2025 | 210.68 K | $5.46 M | 100.00% | 0.48% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 200.00 K | $5.19 M | 100.00% | 0.46% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2025 | 177.67 K | $4.61 M | 0.00% | 0.41% |
| NORTHERN TRUST CORP | 11/14/2025 | 176.89 K | $4.59 M | 106.78% | 0.40% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 167.93 K | $4.35 M | 123.39% | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2025 | 154.34 K | $4.00 M | -56.70% | 0.35% |
| INVESCO LTD. | 11/13/2025 | 132.06 K | $3.42 M | 616.56% | 0.30% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/17/2025 | 125.00 K | $3.24 M | 0.00% | 0.29% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 114.05 K | $2.96 M | 100.00% | 0.26% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 93.35 K | $2.42 M | 100.00% | 0.21% |
| HARVARD MANAGEMENT CO INC | 11/14/2025 | 92.40 K | $2.40 M | -85.51% | 0.21% |
| FORESITE CAPITAL MANAGEMENT V, LLC | 11/14/2025 | 86.29 K | $2.24 M | -75.00% | 0.20% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 86.10 K | $2.23 M | 100.00% | 0.20% |
| ENSIGN PEAK ADVISORS, INC | 11/13/2025 | 70.67 K | $1.83 M | 281.17% | 0.16% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 60.10 K | $1.56 M | 89.02% | 0.14% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 45.24 K | $1.17 M | 109.97% | 0.10% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 30.53 K | $791.51 K | 56,427.78% | 0.07% |
| NUVEEN, LLC | 11/12/2025 | 30.30 K | $785.78 K | 166.41% | 0.07% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 30.00 K | $777.90 K | 100.00% | 0.07% |
| UBS GROUP AG | 11/13/2025 | 27.79 K | $720.67 K | -45.93% | 0.06% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 27.62 K | $716.06 K | 0.54% | 0.06% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Maze Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 97 institutional investors and hedge funds held shares of Maze Therapeutics, Inc.. The most heavily invested institutionals were:
TRV GP IV, LLC: 6.07 M
Frazier Life Sciences Management, L.P.: 4.57 M
ARCH Venture Management, LLC: 4.12 M
Deep Track Capital, LP: 3.95 M
Alphabet Inc.: 2.41 M
AH Capital Management, L.L.C.: 1.7 M
97.99% of Maze Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 43.00 M shares in the last 24 months. This purchase volume represents approximately $1.67 B in transactions.